Thus, we speculate that CAPS exerts its anti-proliferative and anti-migratory action by inhibiting AKT and ERK1/2 signaling pathways, which we, along with other authors, demonstrated are important for MM motility [57,88,89,90]. The gene discussed is MAPK3; the disease is Miyoshi myopathy.